BIO 2025: A few highlights from Day 1
Day 1 of BIO 2025 was all about collaboration: how industry can collaborate with the U.S. government to advance biodefense, how collaboration is key […]
BIO 2025: A few highlights from Day 1 Read More »
Day 1 of BIO 2025 was all about collaboration: how industry can collaborate with the U.S. government to advance biodefense, how collaboration is key […]
BIO 2025: A few highlights from Day 1 Read More »
The 2025 BIO International Convention, hosted by the Biotechnology Innovation Organization (BIO), opens June 16 in Boston, bringing together over 20,000 industry leaders from
Welcome to BIO 2025: The world can’t wait. Read More »
To support and develop the world-leading biotech ecosystem of Massachusetts, Gov. Maura Healey puts a focus on people. Her work for biotech, which has
Gov. Healey, BIO Governor of the Year, boosts people to build biotech Read More »
If innovation is nurtured carefully, biotechnology in food, agriculture, and manufacturing could grow to contribute $416 billion to the U.S. economy by 2030, says
Report: Unleashing bioeconomy’s huge potential requires regulatory updates Read More »
The year in biotech M&A activity got off to a promising start at JPM Week with announcements of some multi-billion-dollar deals. The flurry of
Multi-billion-dollar deals at JPM Week augur a busy BIO CEO 2025 Read More »
The increased interest in JPM Week this year is an indication of an improved dealmaking environment for biotech, according to experts for the Biotechnology
Buzz around JPM Week partnering bodes well for biotech dealmaking, BIO says Read More »
The U.S. bioscience industry generated $3.2 trillion in overall output in 2023, according to the latest report from the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience
U.S. biotech generates $3.2 trillion in a year, report shows Read More »
Pictured, from left: Scott McMurray, Deputy Commissioner, Georgia Quick Start; Dave Penake, CEO, Saol Therapeutics; Margie Battle, Manager, Georgia BioScience Training Center; Megan Heaphy,
Rep. Hank Johnson and BIO tour biotech training facility in Atlanta Read More »
The tide has been rising in biotech investment in 2024—though it has not lifted all boats equally. While the volume of investment improved in
BIO Investor Forum opens with encouraging news on financing Read More »
A guest post by Doug Edgeton, president and CEO of the North Carolina Biotechnology Center. We’re marking two big life sciences anniversaries this year
NCBiotech: 40 years of growing North Carolina life sciences Read More »